NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Saturday, April 05, 2008  
Health Benefits Discovered In Natural Trans Fats, University Of Alberta Study Shows (Online Pharmacy)
Health Benefits Discovered In Natural Trans Fats, University Of Alberta Study Shows
Contrary to popular opinion, not all trans fats are bad for you.
Source: www.medicalnewstoday.com

Researchers Uncover New Genetic Links To Psoriasis
In the first comprehensive study of the genetic basis of psoriasis, researchers at Washington University School of Medicine in St. Louis have discovered seven new sites of common DNA variation that increase the risk of the troublesome skin condition.
Source: www.medicalnewstoday.com

Breakthrough Research In Multiple Myeloma Treatment Flows From IMBCR, The Sole Independent Myelema Research Institute
The Institute for Myeloma and Bone Cancer Research (IMBCR), established in 2004 as a 501 c (3) non-profit organization, is headquartered in West Hollywood, California. IMBCR is the only independent non-profit cancer research institute working to find improved treatment, and ultimately a cure for multiple myeloma, a cancer of the blood cells that reside in the bone marrow.
Source: www.medicalnewstoday.com

Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread
A study led by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) has uncovered how breast tumors use a particular type of molecule to promote metastasis the spread of cancer cells. Metastasis is the cause of approximately 90 percent of all cancer-related deaths. The study is published in the April 4, 2008, issue of Cell.
Source: www.medicalnewstoday.com

FORSTEO(R) Receives Approval From The European Commission For The Treatment Of Glucocorticoid Induced Osteoporosis
Eli Lilly and Company (NYSE: LLY) announced that the European Commission has approved a new indication for FORSTEO(R) (teriparatide [rDNA origin] injection) for the treatment of osteoporosis associated with sustained, systemic glucocorticoid therapy in women and men at increased risk for fracture.
Source: www.medicalnewstoday.com

Does Open Heart Surgery Cause Cognitive Decline? Rigorous Study Says "No"
For many years, assumptions have lingered that Coronary Artery Bypass Surgery Grafting (CABG) produces measurable cognitive impairment, either because of the surgery or use of cardiopulmonary bypass. Recent studies have failed to resolve the issue, because of complications in cognitive testing processes and comparison methods.
Source: www.medicalnewstoday.com

Pieces Coming Together In Parkinson's, Cholesterol Puzzle
In 2006, University of North Carolina at Chapel Hill researchers published a study that found people with low levels of LDL cholesterol are more likely to have Parkinson's disease than people with high LDL levels.
Source: www.medicalnewstoday.com

Genetic Reprogramming
To radiation, chemotherapy, surgery and biological therapies deployed to wage war on cancer, M. D. Anderson researchers have added a new approach diplomacy."In this instance, we're not trying to kill cancer cells, rather we talk to cells and remind them of their regular programming. We persuade them to return to their normal behavior," says Jean-Pierre Issa, M.D., professor in M. D.
Source: www.medicalnewstoday.com

ICAD Receives FDA Approval For Its SecondLook Digital For Use With Fuji's Digital Mammography System
iCAD(R), Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, announced that iCAD's SecondLook(R) Digital Computer-Aided Detection system for mammography received approval from the U.S. Food and Drug Administration for sale with Fujifilm Computed Radiography for Mammography (FCRm) systems.
Source: www.medicalnewstoday.com

Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.